C12N 2501/2324
Interleukin-24
Official title: Interleukin-24 (IL-24)
C12N2501/2324 (Interleukin-24) appears on 1 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 3
- Assignees
- 4
- Inventors
- 10
- Latest grant
- 14 Feb 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of making chimeric antigen receptor-expressing cells26 Feb 2026US 2026/0055157 A1Novartis AG
- Methods of making chimeric antigen receptor-expressing cells26 Nov 2020US 2020/0370012 A1Novartis AG
- Method for producing b cell population and method for producing monoclonal antibody using same5 Mar 2020US 2020/0071410 A1Kaneka Corporation
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.